Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer. / Magni, Lara; Yu, Haoran; Christensen, Nynne M.; Poulsen, Mette H.; Frueh, Alexander; Deshar, Ganga; Johansen, Astrid Z.; Johansen, Julia S.; Pless, Stephan A.; Jørgensen, Niklas R.; Novak, Ivana.

I: Cancer Cell International, Bind 24, Nr. 1, 148, 2024.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Magni, L, Yu, H, Christensen, NM, Poulsen, MH, Frueh, A, Deshar, G, Johansen, AZ, Johansen, JS, Pless, SA, Jørgensen, NR & Novak, I 2024, 'Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer', Cancer Cell International, bind 24, nr. 1, 148. https://doi.org/10.1186/s12935-024-03339-9

APA

Magni, L., Yu, H., Christensen, N. M., Poulsen, M. H., Frueh, A., Deshar, G., Johansen, A. Z., Johansen, J. S., Pless, S. A., Jørgensen, N. R., & Novak, I. (2024). Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer. Cancer Cell International, 24(1), [148]. https://doi.org/10.1186/s12935-024-03339-9

Vancouver

Magni L, Yu H, Christensen NM, Poulsen MH, Frueh A, Deshar G o.a. Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer. Cancer Cell International. 2024;24(1). 148. https://doi.org/10.1186/s12935-024-03339-9

Author

Magni, Lara ; Yu, Haoran ; Christensen, Nynne M. ; Poulsen, Mette H. ; Frueh, Alexander ; Deshar, Ganga ; Johansen, Astrid Z. ; Johansen, Julia S. ; Pless, Stephan A. ; Jørgensen, Niklas R. ; Novak, Ivana. / Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer. I: Cancer Cell International. 2024 ; Bind 24, Nr. 1.

Bibtex

@article{ee5a71e6bdf148fb80ef91dfcc3e2338,
title = "Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer",
abstract = "Background: The purinergic P2X7 receptor (P2X7R) plays an important role in the crosstalk between pancreatic stellate cells (PSCs) and cancer cells, thus promoting progression of pancreatic ductal adenocarcinoma (PDAC). Single nucleotide polymorphisms (SNPs) in the P2X7R have been reported for several cancers, but have not been explored in PDAC. Materials and methods: Blood samples from PDAC patients and controls were genotyped for 11 non-synonymous SNPs in P2X7R and a risk analysis was performed. Relevant P2X7R-SNP GFP variants were expressed in PSCs and cancer cells and their function was assayed in the following tests. Responses in Ca2+ were studied with Fura-2 and dye uptake with YO-PRO-1. Cell migration was monitored by fluorescence microscopy. Released cytokines were measured with MSD assay. Results: Risk analysis showed that two SNPs 474G>A and 853G>A (rs28360447, rs7958316), that lead to the Gly150Arg and Arg276His variants, had a significant but opposite risk association with PDAC development, protecting against and predisposing to the disease, respectively. In vitro experiments performed on cancer cells and PSCs expressing the Gly150Arg variant showed reduced intracellular Ca2+ response, fluorescent dye uptake, and cell migration, while the Arg276His variant reduced dye uptake but displayed WT-like Ca2+ responses. As predicted, P2X7R was involved in cytokine release (IL-6, IL-1β, IL-8, TNF-α), but the P2X7R inhibitors displayed varied effects. Conclusion: In conclusion, we provide evidence for the P2X7R SNPs association with PDAC and propose that they could be considered as potential biomarkers.",
keywords = "IL-6, P2X7R, Pancreatic cancer cells, Pancreatic ductal adenocarcinoma, Pancreatic stellate cells, SNP",
author = "Lara Magni and Haoran Yu and Christensen, {Nynne M.} and Poulsen, {Mette H.} and Alexander Frueh and Ganga Deshar and Johansen, {Astrid Z.} and Johansen, {Julia S.} and Pless, {Stephan A.} and J{\o}rgensen, {Niklas R.} and Ivana Novak",
note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",
year = "2024",
doi = "10.1186/s12935-024-03339-9",
language = "English",
volume = "24",
journal = "Cancer Cell International",
issn = "1475-2867",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer

AU - Magni, Lara

AU - Yu, Haoran

AU - Christensen, Nynne M.

AU - Poulsen, Mette H.

AU - Frueh, Alexander

AU - Deshar, Ganga

AU - Johansen, Astrid Z.

AU - Johansen, Julia S.

AU - Pless, Stephan A.

AU - Jørgensen, Niklas R.

AU - Novak, Ivana

N1 - Publisher Copyright: © The Author(s) 2024.

PY - 2024

Y1 - 2024

N2 - Background: The purinergic P2X7 receptor (P2X7R) plays an important role in the crosstalk between pancreatic stellate cells (PSCs) and cancer cells, thus promoting progression of pancreatic ductal adenocarcinoma (PDAC). Single nucleotide polymorphisms (SNPs) in the P2X7R have been reported for several cancers, but have not been explored in PDAC. Materials and methods: Blood samples from PDAC patients and controls were genotyped for 11 non-synonymous SNPs in P2X7R and a risk analysis was performed. Relevant P2X7R-SNP GFP variants were expressed in PSCs and cancer cells and their function was assayed in the following tests. Responses in Ca2+ were studied with Fura-2 and dye uptake with YO-PRO-1. Cell migration was monitored by fluorescence microscopy. Released cytokines were measured with MSD assay. Results: Risk analysis showed that two SNPs 474G>A and 853G>A (rs28360447, rs7958316), that lead to the Gly150Arg and Arg276His variants, had a significant but opposite risk association with PDAC development, protecting against and predisposing to the disease, respectively. In vitro experiments performed on cancer cells and PSCs expressing the Gly150Arg variant showed reduced intracellular Ca2+ response, fluorescent dye uptake, and cell migration, while the Arg276His variant reduced dye uptake but displayed WT-like Ca2+ responses. As predicted, P2X7R was involved in cytokine release (IL-6, IL-1β, IL-8, TNF-α), but the P2X7R inhibitors displayed varied effects. Conclusion: In conclusion, we provide evidence for the P2X7R SNPs association with PDAC and propose that they could be considered as potential biomarkers.

AB - Background: The purinergic P2X7 receptor (P2X7R) plays an important role in the crosstalk between pancreatic stellate cells (PSCs) and cancer cells, thus promoting progression of pancreatic ductal adenocarcinoma (PDAC). Single nucleotide polymorphisms (SNPs) in the P2X7R have been reported for several cancers, but have not been explored in PDAC. Materials and methods: Blood samples from PDAC patients and controls were genotyped for 11 non-synonymous SNPs in P2X7R and a risk analysis was performed. Relevant P2X7R-SNP GFP variants were expressed in PSCs and cancer cells and their function was assayed in the following tests. Responses in Ca2+ were studied with Fura-2 and dye uptake with YO-PRO-1. Cell migration was monitored by fluorescence microscopy. Released cytokines were measured with MSD assay. Results: Risk analysis showed that two SNPs 474G>A and 853G>A (rs28360447, rs7958316), that lead to the Gly150Arg and Arg276His variants, had a significant but opposite risk association with PDAC development, protecting against and predisposing to the disease, respectively. In vitro experiments performed on cancer cells and PSCs expressing the Gly150Arg variant showed reduced intracellular Ca2+ response, fluorescent dye uptake, and cell migration, while the Arg276His variant reduced dye uptake but displayed WT-like Ca2+ responses. As predicted, P2X7R was involved in cytokine release (IL-6, IL-1β, IL-8, TNF-α), but the P2X7R inhibitors displayed varied effects. Conclusion: In conclusion, we provide evidence for the P2X7R SNPs association with PDAC and propose that they could be considered as potential biomarkers.

KW - IL-6

KW - P2X7R

KW - Pancreatic cancer cells

KW - Pancreatic ductal adenocarcinoma

KW - Pancreatic stellate cells

KW - SNP

U2 - 10.1186/s12935-024-03339-9

DO - 10.1186/s12935-024-03339-9

M3 - Journal article

C2 - 38664691

AN - SCOPUS:85191417683

VL - 24

JO - Cancer Cell International

JF - Cancer Cell International

SN - 1475-2867

IS - 1

M1 - 148

ER -

ID: 391154013